MoneyWorks4Me

Lupin informs about press release

07 Feb 2019 Evaluate

Lupin has informed about submission of a Press Release as regards receipt of USFDA approval for Tadalafil Tablets USP, 20 mg to market a generic version of Eli Lilly and Company's Adcirca Tablets, 20 mg. This is considered as a disclosure pursuant to Regulation 30 of the SEBI [Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..